Uremia: Clinical Trials

2 recruiting. 2 Phase 4.

By phase and status

Phase	Trials	Status
Phase 4	2	Recruiting 2

Follow Uremia: new trials by email Literature Review of Uremia trials Research Report on Uremia

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Anrikefon vs Nalfurafine for Sleep Quality in Hemodialysis Patients With CKD-aP Anrikefon, Nalfurafine - Pruritus Chronic, Kidney Diseases, Chronic	Phase 4	Recruiting	Zhujiang Hospital	50	2026-06-22	2026-08-25
Post-Marketing Clinical Study of Ravulizumab in Participants With Clinical aHUS Ravulizumab - aHUS, Atypical Hemolytic Uremic Syndrome	Phase 4	Recruiting	Alexion Pharmaceuticals, Inc.	20	2025-12-19	2026-04-20

Narrower conditions

Atypical Hemolytic Uremic Syndrome (1)  ·  Bronchiolitis Obliterans Syndrome (1)  ·  Renal Insufficiency, Chronic (1)

Broader conditions

Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Kidney Diseases (2)  ·  Male Urogenital Diseases (2)  ·  Urogenital Diseases (2)  ·  Urologic Diseases (2)  ·  Anemia (1)  ·  Anemia, Hemolytic (1)  ·  Blood Platelet Disorders (1)  ·  Bronchial Diseases (1)  ·  Bronchiolitis (1)  ·  Bronchiolitis Obliterans (1)  ·  Bronchitis (1)  ·  Chronic Disease (1)  ·  Cytopenia (1)

Interventions

TRK 820 (1)  ·  ravulizumab (1)

Sponsors

Alexion Pharmaceuticals, Inc. (1)  ·  Zhujiang Hospital (1)

Countries

China (1)  ·  Japan (1)